Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure
NCT07765823Recruiting
- Sponsor
- King Edward Medical University
- Start
- Jul 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Randomised trial of acetylcysteine in acute liver failure (ALF) (2 arms), sponsored by King Edward Medical University. Primary endpoint: Survival/Mortality rate at 28 days. Started Jul 2026; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
acute liver failure (ALF)
Beyond the preview
Go deeper on NCT07765823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07765823.